The Eptifibatide Injection, cataloged under National Stock Number 6505-01-503-7204, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Mylan Pharmaceuticals Inc. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-503-7204 |
| Primary Part Number | NDC67457-0630-10 |
| Item Name | Eptifibatide Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Mylan Pharmaceuticals Inc |
| Status | ACTIVE |
| American Hospital Formulary Service Classification Number | 920000 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC67457-0630-10 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| INTEGRILIN | 5/9 Secondary reference Schering Corp an Affil of Schering-Plough Corp |
| 02-1713 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM021032 | 5/1 Secondary reference Defense Medical Standardization Board |
| NDC00085-1177-02 | 3/9 Design control — primary reference Schering Corp an Affil of Schering-Plough Corp |
NSN 6505-01-503-7204 is a Eptifibatide Injection, manufactured by Mylan Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-503-7204 has 1 manufacturer part number on file: NDC67457-0630-10 (Mylan Pharmaceuticals Inc).
Key specifications for NDC67457-0630-10: Special Features: 2MG/ML, 100 ML VIAL; SOLUTION IS CLEAR, STERILE, COLORLESS, NON-PYROGENIC; FOR INTRAVENOUS (IV) USE; VIALS SHOULD BE STORED REFRIGERATED 2-8 DEG. C, OR AT ROOM TEMP. FOR UP TO 2 MONTHS ONLY; PROTECT FROM DIRECT LIGHT; DISCARD ANY UNUSED PORTION; TO HELP PATIENTS WITH SEVERE CARDIOVASCULAR DISEASES, HELPS PREVENT CLUMPING OF BLOOD CELLS; Part Name Assigned by Controlling Agency: EPTIFIBATIDE INJECTION 100ML VIAL WITH 2MG/ML EPTIFIBATIDE SOLUTION; American Hospital Formulary Service Classification Number: 920000. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.